Kerusso Capital Management LLC

Position in ABBV — AbbVie Inc.

CIK 2029597 Winston Salem, NC

Position in ABBV

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$5,664,668

+$1,699,391 QoQ

Shares Held

22,511

+23.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

2.07%

of 13F equity value

Holder Rank

#1,240

of 4,152 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 71% Shared 0% None 29%

Healthcare · as of Jun 30, 2026

Kerusso Capital Management LLC holds $25,879,752 across 6 Drug Manufacturers - General names. ABBV ranks #2 (21.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	50,385	$6,365,640
2	ABBV	AbbVie Inc. This page	22,511	$5,664,668
3	AMGN	Amgen Inc	15,282	$5,533,917
4	BMY	Bristol Myers Squibb Co	77,798	$4,482,720
5	MRK	Merck & Co., Inc.	16,017	$2,058,184
6	PFE	Pfizer Inc	73,697	$1,774,623

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,664,668	22,511	+23.5%	Shares	Sole	2026-07-31
2026-03-31	$3,965,277	18,232	+93.0%	Shares	Sole	2026-05-14
2025-12-31	$2,158,088	9,445	+31.6%	Shares	Sole	2026-01-28
2025-09-30	$1,662,225	7,179	-5.2%	Shares	Sole	2025-10-28
2025-06-30	$1,404,957	7,569	-52.7%	Shares	Sole	2025-08-04
2025-03-31	$3,351,062	15,994	+139.7%	Shares	Sole	2025-05-12
2024-12-31	$1,185,614	6,672	+0.2%	Shares	Sole	2025-01-31
2024-09-30	$1,314,821	6,658	+6.5%	Shares	Sole	2024-11-01
2024-06-30	$1,072,343	6,252	—	Shares	Sole	2024-08-06
No filing history on record for this holder in this stock.